125 related articles for article (PubMed ID: 34298587)
1. A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.
Patel DN; Yeagley M; Arturo JF; Falasiri S; Chobrutskiy BI; Gozlan EC; Blanck G
Int J Immunogenet; 2021 Oct; 48(5):409-418. PubMed ID: 34298587
[TBL] [Abstract][Full Text] [Related]
2. Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
Tong WL; Callahan BM; Tu YN; Zaman S; Chobrutskiy BI; Blanck G
Breast Cancer Res Treat; 2019 Jan; 173(1):167-177. PubMed ID: 30229447
[TBL] [Abstract][Full Text] [Related]
3. Lung tumor exome files with T-cell receptor recombinations: a mouse model of T-cell infiltrates reflecting mutation burdens.
Tu YN; Tong WL; Fawcett TJ; Blanck G
Lab Invest; 2017 Dec; 97(12):1516-1520. PubMed ID: 28805806
[TBL] [Abstract][Full Text] [Related]
4. Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
Chobrutskiy BI; Zaman S; Tong WL; Diviney A; Blanck G
J Neurooncol; 2018 Dec; 140(3):697-704. PubMed ID: 30382482
[TBL] [Abstract][Full Text] [Related]
5. Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-α/β V(D)J recombinations correlates with PD-1 expression.
Tu YN; Tong WL; Samy MD; Yavorski JM; Kim M; Blanck G
Int J Cancer; 2017 Jun; 140(11):2568-2576. PubMed ID: 28256716
[TBL] [Abstract][Full Text] [Related]
6. Exploiting adaptive immune receptor recombination read recoveries from exome files to identify subsets of ALL and to establish TCR features that correlate with better outcomes.
Gozlan EC; Chobrutskiy BI; Blanck G
Int J Lab Hematol; 2022 Oct; 44(5):883-891. PubMed ID: 35527672
[TBL] [Abstract][Full Text] [Related]
7. B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
Tu YN; Tong WL; Callahan BM; Chobrutskiy BI; Blanck G
Anticancer Res; 2020 Apr; 40(4):2043-2051. PubMed ID: 32234895
[TBL] [Abstract][Full Text] [Related]
8. TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates.
Clark KR; Tong WL; Callahan BM; Yavorski JM; Tu YN; Blanck G
Int J Immunogenet; 2019 Feb; 46(1):31-37. PubMed ID: 30474304
[TBL] [Abstract][Full Text] [Related]
9. Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family members.
Diaz MJ; Chobrutskiy BI; Zaman S; Blanck G
Cancer Treat Res Commun; 2020; 24():100196. PubMed ID: 32769037
[TBL] [Abstract][Full Text] [Related]
10. TcR-α recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers.
Mai AT; Tong WL; Tu YN; Blanck G
Int Immunol; 2018 Feb; 30(1):35-40. PubMed ID: 29361059
[TBL] [Abstract][Full Text] [Related]
11. Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-γ/δ Recombinations.
Tu YN; Tong WL; Yavorski JM; Blanck G
Cancer Microenviron; 2018 Jun; 11(1):41-49. PubMed ID: 29357011
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-β VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
Samy MD; Tong WL; Yavorski JM; Sexton WJ; Blanck G
Cancer Immunol Immunother; 2017 Mar; 66(3):403-410. PubMed ID: 27995306
[TBL] [Abstract][Full Text] [Related]
13. Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival.
Kinskey JC; Tu YN; Tong WL; Yavorski JM; Blanck G
Cancer Microenviron; 2018 Jun; 11(1):51-59. PubMed ID: 29404962
[TBL] [Abstract][Full Text] [Related]
14. Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells.
Mwangi KW; Kamita MK; Waweru JW; Sayed S; Figueroa JD; Ambs S; Cios KJ; Blanck G; Makokha FW
Breast Cancer Res Treat; 2023 May; 199(1):207-214. PubMed ID: 36882607
[TBL] [Abstract][Full Text] [Related]
15. Chemical features of melanoma tumor resident TRG CDR3s associated with better survival probabilities.
Agnila DRL; Huda TI; Eakins RA; Patel DN; Hsiang M; Chobrutskiy A; Chobrutskiy BI; Blanck G
Melanoma Res; 2023 Aug; 33(4):275-282. PubMed ID: 37222076
[TBL] [Abstract][Full Text] [Related]
16. Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: Evidence for high level B-cell infiltrates in breast cancer.
Tong WL; Tu YN; Samy MD; Sexton WJ; Blanck G
Hum Vaccin Immunother; 2017 Mar; 13(3):501-506. PubMed ID: 28085544
[TBL] [Abstract][Full Text] [Related]
17. Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis.
Zaman S; Chobrutskiy BI; Patel JS; Diviney A; Tu YN; Tong WL; Gill T; Blanck G
Viral Immunol; 2020 Jun; 33(5):404-412. PubMed ID: 32315578
[TBL] [Abstract][Full Text] [Related]
18. Delineation of a T-cell receptor CDR3-cancer mutanome aromaticity factor, assessable via blood samples, that facilitates the establishment of survival distinctions in bladder cancer.
Waweru JW; Mwangi KW; Barker VR; Gozlan EC; Yeagley M; Blanck G; Makokha FW
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4359-4366. PubMed ID: 36098856
[TBL] [Abstract][Full Text] [Related]
19. Immune receptor CDR3 chemical features that preserve sequence information are highly efficient in reflecting survival distinctions: A pan-cancer analysis.
Mcbreairty BE; Chobrutskiy BI; Chobrutskiy A; Gozlan EC; Diaz MJ; Blanck G
Biomed Rep; 2022 Aug; 17(2):68. PubMed ID: 35815190
[TBL] [Abstract][Full Text] [Related]
20. Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.
Yeagley M; Chobrutskiy BI; Gozlan EC; Medikonda N; Patel DN; Falasiri S; Callahan BM; Huda T; Blanck G
Pediatr Hematol Oncol; 2021 Apr; 38(3):251-264. PubMed ID: 33616477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
